Cerebrospinal fluid carnitine levels in patients with Parkinson's disease

被引:12
作者
JimenezJimenez, FJ
Rubio, JC
Molina, JA
Martin, MA
Campos, Y
BenitoLeon, J
OrtiPareja, M
Gasalla, T
Arenas, J
机构
[1] UNIV ALCALA DE HENARES, HOSP PRINCIPE ASTURIAS, DEPT NEUROL, ALCALA DE HENARES, SPAIN
[2] HOSP 12 OCTUBRE, DEPT BIOCHEM, E-28041 MADRID, SPAIN
[3] HOSP 12 OCTUBRE, DEPT NEUROL, E-28041 MADRID, SPAIN
关键词
Parkinson's disease; oxidative stress; carnitine; mitochondrial function; plasma; cerebrospinal fluid;
D O I
10.1016/S0022-510X(96)00259-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We assessed free carnitine (FC) and acyl-carnitine esters (AC) in both CSF and plasma from 29 patients with diagnostic criteria for PD, and from 29 healthy matched-controls. FC and AC levels in both CSF and plasma did not differ significantly between PD patients and controls, they were not influenced significantly by anti-parkinsonian drugs, and did not correlate with age at onset, duration and severity of PD. These results suggest that CSF carnitine levels are apparently unrelated with the risk for PD. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:183 / 185
页数:3
相关论文
共 20 条
[1]   BRAIN PEROXIDASE AND CATALASE IN PARKINSON DISEASE [J].
AMBANI, LM ;
VANWOERT, MH ;
MURPHY, S .
ARCHIVES OF NEUROLOGY, 1975, 32 (02) :114-118
[2]   ACETYL-LEVO-CARNITINE PROTECTS AGAINST MPTP-INDUCED PARKINSONISM IN PRIMATES [J].
BODISWOLLNER, I ;
CHUNG, E ;
GHILARDI, MF ;
GLOVER, A ;
ONOFRJ, M ;
PASIK, P ;
SAMSON, Y .
JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1991, 3 (01) :63-72
[3]   MUSCLE CARNITINE DEFICIENCY AND LIPID STORAGE MYOPATHY IN PATIENTS WITH MITOCHONDRIAL MYOPATHY [J].
CAMPOS, Y ;
HUERTAS, R ;
BAUTISTA, J ;
GUTIERREZ, E ;
APARICIO, M ;
LORENZO, G ;
SEGURA, D ;
VILLANUEVA, M ;
CABELLO, A ;
ALESSO, L ;
ARENAS, J .
MUSCLE & NERVE, 1993, 16 (07) :778-781
[4]   PROPIONYLCARNITINE EXCRETION IN PROPIONIC AND METHYLMALONIC ACIDURIAS - A CAUSE OF CARNITINE DEFICIENCY [J].
DIDONATO, S ;
RIMOLDI, M ;
GARAVAGLIA, B ;
UZIEL, G .
CLINICA CHIMICA ACTA, 1984, 139 (01) :13-21
[5]  
DIDONATO S, 1994, MITOCHONDRIAL DISORD, P145
[6]   THE OXIDANT STRESS HYPOTHESIS IN PARKINSONS-DISEASE - EVIDENCE SUPPORTING IT [J].
FAHN, S ;
COHEN, G .
ANNALS OF NEUROLOGY, 1992, 32 (06) :804-812
[7]  
Fahn S., 1987, RECENT DEV PARKINSON, P153
[8]   EFFECT OF ACETYL-L-CARNITINE ON 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) NEUROTOXICITY [J].
HARIK, SI ;
HRITZ, MA .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (10) :2170-2172
[9]   PARKINSONISM - ONSET PROGRESSION AND MORTALITY [J].
HOEHN, MM ;
YAHR, MD .
NEUROLOGY, 1967, 17 (05) :427-&
[10]  
HOPPEL C, 1992, L CARNITINE ITS ROLE, P5